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We present the current situation of the NPRD from
Bulgaria, Romania and Hungary: three different coun-
tries confronted with the same problems and limits, and
most probably not so different realities.
Bulgaria: the NPRD was officially launched on 1 Janu-
ary 2009. The draft for rare diseases and orphan drugs
programme was prepared by BAPES and proposed to
the Bulgarian Ministry of Health (MoH) in November
2004. The national plan includes 9 priorities (total bud-
get 11 294 515 Euro).
Romania: RPWA established RONARD – and orga-
nised the first working groups on a National Plan for
RD on 9 August 2007. 1-2 November, RONARD orga-
nised the first National Conference on RD. 29 February
2008– signed a partnership agreement with MoH –
NPRD with 6 priorities. The first national programme
on RD started in June 2008. Still there is no NPRD in
the National Strategy for Health.
Hungary: there are several improvements but still
before designing the Plan. HUFERDIS and enthusiastic
professionals pushed it, but they have four running
national health plans, and there is no more money for a
new one.
In all three countries, Patient Organisations and medi-
cal professionals are the main engine for drafting and
lobbying for a national strategy on RD. They organised
information campaigns with stronger and stronger
impact, help lines, contribute in designing social and
medical health care services, initiate therapies, respite
care, involve in research and clinical trials, etc. They
organised working groups with members of the national
alliances, networks and advocates at national level.
The Plan should be promoted both to parliament
members and Ministry of Health. More “actors” have to
be involved because RD patients need varied social assis-
tance as much as medical care.
EURORDIS offered specific tools for lobby and advo-
cacy actions toPOs. Recommendations and Communica-
tions of the EC give the best tool to promote RD as a
public health and research priority.
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